STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
Loan & DebtApr 30, 2026, 04:30 PM

PAHC Increases Revolving Credit Commitment by $125M to $435M

AI Summary

Phibro Animal Health Corporation entered into Amendment No. 1 to its Credit Agreement on April 28, 2026. This amendment significantly increases the company's revolving credit commitment by $125,000,000, raising the total commitment from $310,000,000 to $435,000,000. The increased commitment provides the company with enhanced financial flexibility and liquidity.

Key Highlights

  • Revolving credit commitment increased by $125,000,000.
  • Total revolving credit commitment now stands at $435,000,000.
  • Previous revolving credit commitment was $310,000,000.
  • Amendment No. 1 to the Credit Agreement was entered into on April 28, 2026.
  • Coöperatieve Rabobank U.A., New York Branch, serves as the administrative agent.
PAHC
Biotechnology: Pharmaceutical Preparations
PHIBRO ANIMAL HEALTH CORP

Price Impact